Axon Enterprise, Inc $AXON Stake Boosted by Geode Capital Management LLC

Geode Capital Management LLC boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 5.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,072,186 shares of the biotechnology company’s stock after acquiring an additional 115,349 shares during the quarter. Geode Capital Management LLC owned 2.64% of Axon Enterprise worth $1,713,332,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Brighton Jones LLC bought a new position in shares of Axon Enterprise during the 4th quarter valued at $480,000. CWM LLC boosted its stake in shares of Axon Enterprise by 3.2% during the 1st quarter. CWM LLC now owns 4,713 shares of the biotechnology company’s stock worth $2,479,000 after acquiring an additional 147 shares in the last quarter. Signaturefd LLC increased its holdings in shares of Axon Enterprise by 10.4% during the 1st quarter. Signaturefd LLC now owns 838 shares of the biotechnology company’s stock valued at $441,000 after acquiring an additional 79 shares during the last quarter. Sigma Planning Corp lifted its holdings in Axon Enterprise by 50.3% in the 1st quarter. Sigma Planning Corp now owns 2,472 shares of the biotechnology company’s stock worth $1,300,000 after purchasing an additional 827 shares during the last quarter. Finally, Apollon Wealth Management LLC boosted its position in Axon Enterprise by 63.0% during the first quarter. Apollon Wealth Management LLC now owns 2,018 shares of the biotechnology company’s stock worth $1,061,000 after purchasing an additional 780 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Axon Enterprise

In other news, CFO Brittany Bagley sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer owned 93,592 shares of the company’s stock, valued at $66,813,456.96. The trade was a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Friday, November 7th. The shares were sold at an average price of $591.04, for a total transaction of $5,910,400.00. Following the completion of the transaction, the chief executive officer directly owned 3,023,982 shares of the company’s stock, valued at approximately $1,787,294,321.28. The trade was a 0.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 52,041 shares of company stock valued at $36,794,077. 5.70% of the stock is owned by insiders.

Axon Enterprise Trading Down 0.5%

AXON stock opened at $569.51 on Thursday. Axon Enterprise, Inc has a one year low of $469.24 and a one year high of $885.91. The stock has a market cap of $44.94 billion, a price-to-earnings ratio of 140.62, a price-to-earnings-growth ratio of 29.49 and a beta of 1.45. The company has a fifty day moving average price of $709.82 and a two-hundred day moving average price of $735.72. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, November 4th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $710.64 million during the quarter, compared to the consensus estimate of $704.83 million. During the same period in the prior year, the business earned $1.45 earnings per share. Axon Enterprise’s quarterly revenue was up 30.6% compared to the same quarter last year. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Northland Securities set a $800.00 target price on Axon Enterprise in a report on Tuesday, August 5th. JMP Securities restated a “market outperform” rating and set a $825.00 price objective on shares of Axon Enterprise in a report on Monday, September 29th. Needham & Company LLC reissued a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a report on Wednesday, September 24th. Wall Street Zen cut shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, Piper Sandler reduced their price target on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $810.71.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.